Literature DB >> 6368400

The significance of the HBeAg/anti-HBe system in hemodialysis patients. A multicenter study.

F Fiaccadori, S David, G Faggion, N Feriani, C Ferrari, V Franco, T Giuberti, C Grutta D'Auria, G La Greca, G Magnani.   

Abstract

The HBeAg/anti-HBe system was studied as a marker of infectivity and chronic progressive liver disease in 460 hemodialysis patients. The importance of HBeAg as an index of infectivity was confirmed in that it was present simultaneously with specific DNA polymerase (31 patients) and by the presence of widely diffuse core particles in the hepatocyte nuclei (revealed by biopsy in six patients). In contrast, HBeAg showed no useful correlation with progressive liver disease, the absence of which was confirmed in all cases by biochemical and histological studies.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6368400     DOI： 10.1007/bf01641020

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  30 in total

1.  Clinical and pathogenetic aspects on chronic active hepatitis.

Authors:  J Lindberg
Journal:  Scand J Infect Dis Suppl       Date:  1978

2.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

3.  New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.

Authors:  L O Magnius; J A Espmark
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

4.  Radioimmunoassay in the detection of the hepatitis B e antigen/antibody system in asymptomatic carriers of hepatitis B surface antigen. Correlation with serum Dane particle associated DNA polymerase activity.

Authors:  G Pastore; A R Zanetti; P Ferroni; P Dentico; G Angarano; O Schiraldi
Journal:  Infection       Date:  1979       Impact factor: 3.553

5.  The significance of serologic, histologic, and immunohistologic findings in the prognosis of 88 asymptomatic carriers of hepatitis B surface antigen.

Authors:  H H Dormeyer; W Arnold; H Schönborn; B Braun; O Klinge; U Pfeifer; J Knolle; G Hess; P Kryger; J O Nielsen; K H Meyer zum Büschenfelde
Journal:  J Infect Dis       Date:  1981-07       Impact factor: 5.226

6.  Letter: Infectivity of serum containing HBsAg and antibody to e antigen.

Authors:  K R Berquist; J E Maynard; B L Murphy
Journal:  Lancet       Date:  1976-05-08       Impact factor: 79.321

7.  Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease.

Authors:  N Eleftheriou; H C Thomas; J Heathcote; S Sherlock
Journal:  Lancet       Date:  1975-12-13       Impact factor: 79.321

8.  e Antigen-antibody system as indicator of liver damage in patients with hepatitis-B antigen.

Authors:  N El Sheikh; I L Woolf; R M Galbraith; A L Eddleston; I W Dymock; R Williams
Journal:  Br Med J       Date:  1975-11-01

9.  Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure.

Authors:  H J Alter; L B Seeff; P M Kaplan; V J McAuliffe; E C Wright; J L Gerin; R H Purcell; P V Holland; H J Zimmerman
Journal:  N Engl J Med       Date:  1976-10-21       Impact factor: 91.245

10.  Detection of e antigen and antibody: correlations with hapatitis B surface and hepatitis B core antigens, liver disease, and outcome in hepatitis B infections.

Authors:  C G Trepo; L O Magnius; R A Schaefer; A M Prince
Journal:  Gastroenterology       Date:  1976-11       Impact factor: 22.682
View more
  1 in total

1.  [Relation between the serological and electromicroscopic results of viral hepatitis].

Authors:  G X Shen; M Gesemann; E K Kuwert; R Dermietzel
Journal:  Acta Acad Med Wuhan       Date:  1985
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.